Bronson
Stocking | @BronsonStocking | Posted:
Feb 27, 2021 7:50 PM
The Trump era's Operation
Warp Speed is the gift that keeps on giving. On Saturday, the Food and Drug
Administration (FDA) approved Johnson & Johnson's Wuhan coronavirus
vaccine, making it the third coronavirus vaccine approved in the United
States.
The agency's
emergency-use approval comes one day after an advisory panel for the FDA
recommended drugmaker Johnson & Johnson's vaccine candidate for
approval.
Johnson & Johnson's
vaccine is the third coronavirus vaccine to receive FDA approval, but the first
vaccine requiring just one shot for vaccination. The drug showed a 66 percent
effectiveness against moderate to severe COVID-19 infections and about an 85
percent effectiveness against the most serious illnesses. While two other
FDA-approved vaccines have efficacy rates in the 90s, Johnson & Johnson's
drug was shown to prevent 100 percent of hospitalizations in a clinical study
of around 44,000 participants in the United States.
"This is a vaccine
to prevent you from going to the hospital and dying at a level that’s certainly
comparable" to the Pfizer and Moderna vaccines, said Dr. Paul Offit, a
member of the FDA's advisory panel and vaccine expert at Children's Hospital of
Philadelphia.
Unlike the vaccines
developed by Pfizer and Moderna, Johnson & Johnson's vaccine candidate does
not to be stored in freezers and remains stable for months in refrigerated
temperatures.
Around 3 to 4 million
doses of the new vaccine are expected to be shipped out as early as next week.
The company has pledged to deliver some 20 million doses by April and 100
million by late June.
No comments:
Post a Comment